Back to search

Article

Hepatic Steatosis is Generated by the Gut Microbiota-Mitochondria Axis via 2-oleolyl Glycerol and Reverted by Functional Foods

2024-07-10

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a serious health problem, and recent evidence indicates that gut microbiota plays a key role in its development. It is known that 2-oleoyl glycerol (2-OG) produced by the gut microbiota is associated with hepatic fibrosis, but it is not known whether this metabolite is involved in the development of hepatic steatosis. The aim of this study was to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
33a0c241-a0fa-5e31-8af9-188796fb5cff
DOI
10.20944/preprints202407.0745.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hepatic Steatosis is Generated by the Gut Microbiota-Mitochondria Axis via 2-oleolyl Glycerol and Reverted by Functional FoodsDOI 10.20944/preprints202407.0745.v1
Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgerySemantic proximity
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity
Microbial and Transcriptomic Profiling Reveals Diet-Related Alterations of Metabolism in Metabolic Disordered MiceSemantic proximity
Antimicrobial emulsifier – glycerol monolaurate impacts gut micobiome inducing distinct effects on metabolic syndrome in low-fat diet fed miceSemantic proximity
A new dietary rat model fully recapitulates metabolic dysfunction-associated steatotic liver disease pathophysiology and mimics human disease with advanced liver fibrosis and portal hypertensionSemantic proximity
The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat dietSemantic proximity
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential for applications in human health and diseaseSemantic proximity
A multiomics comparison of weight loss interventions shows the distinct effects of bariatric surgery and intermittent fasting on hepatic metabolismSemantic proximity
Fructose catabolism and its metabolic effects: Exploring host–microbiota interactions and the impact of ethnicitySemantic proximity
Gut Microbiota and Metabolite Dynamics in a MASLD-Associated Liver Fibrosis In Vivo Model: An Integrative Multi-Omic PerspectiveSemantic proximity
Energy-controlled high-fat diets effectively ameliorate MASLD and improve overall healthSemantic proximity
A metabonomics study of the modulation of lipid and bile acid metabolism by the gut microbiota and consequences on obesity and fatty liver diseaseSemantic proximity
Select a neighboring publication to make it the new centre.